Ardelyx Inc. buy marge
Start price
13.05.17
/
50%
€6.86
Target price
12.10.17
€6.95
Performance (%)
-2.63%
End price
12.10.17
€6.67
Summary
This prediction ended on 12.10.17 with a price of €6.67. With a performance of -2.63%, the BUY prediction for Ardelyx Inc. by marge closed slightly in the red. marge has 50% into this predictionArdelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ardelyx Inc. | -5.381% | -5.381% | 61.132% | 1.322% |
| iShares Core DAX® | -0.258% | -0.962% | 15.475% | 16.944% |
| iShares Nasdaq 100 | 2.964% | 4.747% | 30.457% | 56.973% |
| iShares Nikkei 225® | 1.217% | 0.285% | 5.780% | 5.634% |
| iShares S&P 500 | 1.732% | 2.635% | 25.189% | 48.524% |
Comments by marge for this prediction
In the thread Ardelyx Inc. diskutieren